This should be trading a minimum of 2x higher, and
Post# of 72440
So far: 3 different drugs, in clinical trials for 4 different medicals needs -- one of which (oral mucositis) has no effective treatment.
How many biotechs have a higher market cap than this, and don't have even ONE drug in any clinical trial, much less 4 clinical trials?